DEC 24, 2015 10:32 AM PST

Immunotherapy Better for Non-Small-Cell Lung Cancer Patients

WRITTEN BY: Kara Marker
Some tumor cells in patients with non-small-cell lung cancer (NSCLC) express programmed death ligand 1 (PD-L1) that binds to its receptor (PD-1) which is expressed by immune cells. This interaction inhibits T cells’ ability to attack cancerous cells, allowing the tumor to grow unimpeded (Oncology). In attempt to block this inhibition, scientists are developing an immunotherapy that targets PD-1 and allows T cells to properly fight off growing cancer cells.

From the University of California, Los Angeles, researchers studied a group of patients with NSCLC to see how PD-1 immunotherapy compares with traditional chemotherapy.  Out of over a thousand participants, 75 percent had at least one percent of PD-L1 expressed by their tumor cells. The study results, which were published in The Lancet, showed groups of NSCLC patients receiving the PD-1 immunotherapy both experienced significant tumor shrinkage and lived longer than the patients who received chemotherapy.

"For most patients, this now offers data showing that immunotherapy leads to superior clinical outcomes with a side effect profile that is generally favorable to our traditional therapies," said Dr. Edward Garon, senior author of the paper.

Indeed, PD-1 immunotherapy utilizes the antibody pembrolizumab, which is significantly less toxic to cancer patients than chemicals used in chemotherapy.

NSCLC like squamous cell carcinoma, adenocarcinoma, and large cell carcinoma are the most common types of lung cancer, making up 85 percent of all cases of lung cancer (American Cancer Society). Lung cancer is the leading cause of cancer death.

"This treatment provides real hope of long-lasting responses," Garon added.

For more about lung cancer, watch the following video.

Source: University of California, Los Angeles
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 02, 2021
Immunology
Pumping the Brakes on Stomach Cancer Progression
FEB 02, 2021
Pumping the Brakes on Stomach Cancer Progression
By the time stomach cancer is diagnosed, it’s often bad news for patients. The disease often presents with relativ ...
APR 01, 2021
Immunology
The Curious Case of COVID Immunity...a Threat to Vaccination Efforts?
APR 01, 2021
The Curious Case of COVID Immunity...a Threat to Vaccination Efforts?
After COVID infection, there’s a spectrum of diversity in how long antibodies against the coronavirus hang around& ...
APR 21, 2021
Health & Medicine
Topical Probiotics Are a Beneficial Acne Treatment
APR 21, 2021
Topical Probiotics Are a Beneficial Acne Treatment
Research underway is showing topical probiotics to be a beneficial treatment for acne vulgaris. Topical probiotics are a ...
MAY 06, 2021
Immunology
COVID Vaccines Don't Protect Everyone
MAY 06, 2021
COVID Vaccines Don't Protect Everyone
New research has revealed that COVID-19 vaccines may not work as effectively in those whose immune systems have been neg ...
MAY 19, 2021
Drug Discovery & Development
Combination Immunotherapy Shows Promise in Treating HIV
MAY 19, 2021
Combination Immunotherapy Shows Promise in Treating HIV
  Researchers have found that a new combination immunotherapy, alongside antiretroviral therapy (ART), is effective ...
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
Loading Comments...